BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 15733463)

  • 1. [The combined therapy of intervention, operation and biology in patients with middle-advanced renal cell carcinoma].
    Song XS; He ZZ; Yin JB; Zhang RK; Che XY; Wang JB
    Zhonghua Wai Ke Za Zhi; 2004 Dec; 42(23):1450-2. PubMed ID: 15733463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Results of endovascular interventions (embolization and chemoembolization) in the treatment of operable and extensive kidney cancer].
    Granov AM; Gorelov AI; Gershanovich ML; Karelin MI; Vorob'ev AV; Filov VA; Stukov AN
    Vopr Onkol; 1998; 44(6):711-4. PubMed ID: 10087971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Embolization for renal carcinoma].
    Li S; Dong Z; Li J
    Zhonghua Wai Ke Za Zhi; 1998 Feb; 36(2):101-2. PubMed ID: 11715549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Improvement in the prognosis of renal cell carcinoma by percutaneous transvascular embolization].
    Stösslein F; Schwenke A; Münster W; Köhler H; Mebel M; Raatzsch H; Steude U; Krosegk G
    Z Urol Nephrol; 1987 Oct; 80(10):577-86. PubMed ID: 3433986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of advanced Wilms' tumor].
    Li MJ; Huang Y; Tang DX; Zhou YB; Tang HF; Liang JF
    Zhonghua Zhong Liu Za Zhi; 2006 Oct; 28(10):791-5. PubMed ID: 17366799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Preoperative and palliative embolization of renal cell carcinomas: follow-up of 49 patients].
    Hallscheidt P; Besharati S; Noeldge G; Haferkamp A; Lopez R; Kauffmann GW
    Rofo; 2006 Apr; 178(4):391-9. PubMed ID: 16612730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New treatments for metastatic kidney cancer.
    Mancuso A; Sternberg CN
    Can J Urol; 2005 Feb; 12 Suppl 1():66-70; discussion 105. PubMed ID: 15780170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of oncological outcome after resection of locally recurrent renal cell carcinoma.
    Margulis V; McDonald M; Tamboli P; Swanson DA; Wood CG
    J Urol; 2009 May; 181(5):2044-51. PubMed ID: 19286220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrative tumor board: metastatic renal cell carcinoma: medical oncology.
    Gupta SK; Vogelzang N
    Integr Cancer Ther; 2004 Mar; 3(1):26-9. PubMed ID: 15035871
    [No Abstract]   [Full Text] [Related]  

  • 10. Percutaneous radiofrequency ablation with transarterial embolization is useful for treatment of stage 1 renal cell carcinoma with surgical risk: results at 2-year mean follow up.
    Arima K; Yamakado K; Kinbara H; Nakatsuka A; Takeda K; Sugimura Y
    Int J Urol; 2007 Jul; 14(7):585-90; discussion 590. PubMed ID: 17645597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of transcatheter renal arterial embolization combined with cryoablation on regulatory CD4+CD25+ T lymphocytes in the peripheral blood of patients with advanced renal carcinoma.
    Li Y; Guo Z; Liu CF; Xing WG; Si TG; Liu F; Guo XY; Xing JZ
    Cryobiology; 2012 Aug; 65(1):56-9. PubMed ID: 22521783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of preoperative radiochemotherapy on postoperative course and survival in patients with locally advanced squamous cell oesophageal carcinoma.
    Mariette C; Piessen G; Lamblin A; Mirabel X; Adenis A; Triboulet JP
    Br J Surg; 2006 Sep; 93(9):1077-83. PubMed ID: 16779882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Combination therapy of localized and locally-advanced renal-cell cancer using preoperative arterial embolization].
    Karelin MI; Atroshchenko AV; Shkol'nik MI; Leonenkov RV; Belov AD; Kharitonov MV
    Vopr Onkol; 2008; 54(1):95-7. PubMed ID: 18416067
    [No Abstract]   [Full Text] [Related]  

  • 14. No role of adjuvant systemic therapy after complete metastasectomy in metastatic renal cell carcinoma?
    Kwak C; Park YH; Jeong CW; Lee SE; Ku JH
    Urol Oncol; 2007; 25(4):310-6. PubMed ID: 17628297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Transabdominal radical nephrectomy for renal cell carcinoma: an experience on 155 patients].
    Chen XF; Zhou FJ; Han H; Qin ZK; Liu ZW; Yu SL; Li YH; Wang H; Hou GL
    Ai Zheng; 2007 May; 26(5):528-32. PubMed ID: 17672946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant interleukin-2, interferon-alpha, and 5-fluorouracil immunochemotherapy after radical nephrectomy for locally advanced renal cell carcinoma.
    Hong SK; Kwak C; Lee SE
    Urology; 2005 Sep; 66(3):518-22. PubMed ID: 16140069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Renal arterial embolization for renal cell carcinoma].
    Yamasaki Y; Tochigi H; Tajima K; Yanagawa M; Hayashi N; Sakurai M; Yamakawa K; Tada S; Nakamura K; Hirano T
    Hinyokika Kiyo; 1985 Mar; 31(3):387-95. PubMed ID: 4025078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Are immunotherapy and chemotherapy in metastatic renal cell cancer out?].
    Schmitz-Dräger BJ
    Urologe A; 1992 Jul; 31(4):213-4. PubMed ID: 1514204
    [No Abstract]   [Full Text] [Related]  

  • 19. Impact of C-reactive protein kinetics on survival of patients with metastatic renal cell carcinoma.
    Saito K; Tatokoro M; Fujii Y; Iimura Y; Koga F; Kawakami S; Kihara K
    Eur Urol; 2009 May; 55(5):1145-53. PubMed ID: 18930583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative study of the patients with renal cell carcinoma before and after 1980].
    Onishi T; Machida T; Masuda F; Suzuki M; Furuta N
    Hinyokika Kiyo; 1990 Aug; 36(8):879-85. PubMed ID: 2239588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.